Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 59,178Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pfizer Canada ULC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pfizer Canada ULC

arrow
Process Development
Not Confirmed

Pfizer Canada ULC

Country
arrow
Process Development
Not Confirmed

Binimetinib

Brand Name : MEKTOVI

Patent Number : 2771775

Filing Date : 2010-08-27

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-08-27

Date Granted : 2015-01-20

blank

02

Pfizer Canada ULC

arrow
Process Development
Not Confirmed

Pfizer Canada ULC

Country
arrow
Process Development
Not Confirmed

Binimetinib

Brand Name : MEKTOVI

Patent Number : 2478374

Filing Date : 2003-03-13

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-03-13

Date Granted : 2009-01-06

blank

03

Pfizer Canada ULC

arrow
Process Development
Not Confirmed

Pfizer Canada ULC

Country
arrow
Process Development
Not Confirmed

Binimetinib

Brand Name : MEKTOVI

Patent Number : 2907704

Filing Date : 2014-03-19

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-03-19

Date Granted : 2023-01-10

blank